N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
about
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunitiesOxidative Stress in Neurodegenerative DiseasesAnimal models and high field imaging and spectroscopyN-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataA review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of TrichotillomaniaDietary thiols in exercise: oxidative stress defence, exercise performance, and adaptationNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Central nervous system uptake of intranasal glutathione in Parkinson's disease.Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementationFetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis.Sensitivity and specificity of human brain glutathione concentrations measured using short-TE (1)H MRS at 7 T.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Proceedings of the workshop on Cerebellum, Basal Ganglia and Cortical Connections Unmasked in Health and Disorder held in Brno, Czech Republic, October 17th, 2013.Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained.Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.Cognitive effects of adjunctive N-acetyl cysteine in psychosis.Targeting urate to reduce oxidative stress in Parkinson disease.Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.DJ-1 as a Biomarker of Parkinson's Disease.Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival.N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.A pilot study to assess the effect of acute exercise on brain glutathione.N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione.The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition.Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.Prevention of hypoglycemia-induced hippocampal neuronal death by N-acetyl-L-cysteine (NAC).Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß.N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.Current perspective of mitochondrial biology in Parkinson's disease.Extremely Low Frequency Magnetic Field (ELF-MF) Exposure Sensitizes SH-SY5Y Cells to the Pro-Parkinson's Disease Toxin MPP(.).N-acetylcysteine protects against motor, optomotor and morphological deficits induced by 6-OHDA in zebrafish larvae.
P2860
Q24568289-EE5F46E6-BC5F-4BFB-9E0D-4314D4FE4C93Q26801239-615356D7-C1B4-4B67-B88F-1AFAD6AC9E51Q28662048-A5CAFE2E-91A8-4B15-9A5D-BC3D7D26F20EQ30000089-8003990C-1240-4FBA-851B-4155CFD0B56CQ30365907-2971E0ED-E979-4565-B2E4-CE0522FCA2BCQ31028468-1D9AC546-3EC2-4AF3-B154-FABEC68EBDF2Q33584684-E2863217-0DC8-4E37-8878-AC6979D6CAA0Q33612951-E7DDB0A8-32FA-429E-82D1-7DC424545AB0Q33783000-3A948ACB-5062-4BE3-9B60-C07AD780F627Q33831798-F88D4B19-C5CF-458B-B108-9D81B1E6F5BAQ33917288-E46E444E-FFA6-4C57-B4AD-8A70DD249418Q35060309-1DA40B23-821F-46C3-A197-1E1D1A9234E0Q36421226-44FCCC58-B21B-4D9B-8FA1-FB4978399EF0Q36803821-1F71A856-759F-4C05-A090-ED7FE3C3FA78Q36925905-365EE977-24F4-4F39-B7A8-A0F90FCE4217Q37279959-D202BC9B-1C71-4BEC-8F2B-373315AABC98Q38748531-84263021-482C-4356-BD0D-87A2D9B41E01Q38841508-69700A86-E312-4D74-99EA-3A6720319CE9Q39018853-84A202C0-6EF9-4D4F-9AB4-A18C0AF166A4Q39147992-E020CAFD-1217-4429-A86E-7418D215ECBAQ39379023-43D37E65-DEF6-4D72-8D79-F255ED08EFA8Q41858286-46BDFFC9-C1CC-42F0-82D4-19CB7B5E1CF5Q42870393-E0ACC65F-4A29-4BF2-897B-C4DCE7C20FDEQ46259808-7317019E-C588-4550-BCBB-BADD0BB7902CQ46398250-66E12A1F-A7F4-4EE4-B32B-56AED12FC648Q47275184-CE3F2C0E-96F4-410C-931C-A0202DC5AD27Q47316338-2035D46A-5517-4A3C-A913-2E5A0776E5CFQ47919698-912131C4-781F-4192-A442-8DE04ADAB19EQ48091363-7BD8599B-DD0B-41F2-A847-C729DA8721F5Q48100438-A9DFCCAF-D062-43C3-95E5-00098BEF2192Q48141989-34E7BC39-34A4-4A50-8BC7-BC7968485EF0Q48146159-D1736A27-ED7B-420F-8355-B413D0ECD212Q48176779-492511AA-182A-41D1-A041-C46219D36E0AQ48475079-EEED4C04-3580-4862-9A6D-8A2914FDF3C1Q50281040-72A8F905-EAAF-43C1-B425-14779F9FE190Q52351688-2ED89085-CB44-43F6-A28F-127B90773FC5Q52927393-EB8E5826-3C38-4F4B-B57C-0CE7DB6B2FC0Q55265287-3D95D8A9-1296-4377-9A4E-BFFAACC3C88E
P2860
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@en
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@nl
type
label
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@en
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@nl
prefLabel
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@en
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
@nl
P2093
P2860
P1476
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases
@en
P2093
James C Cloyd
Lisa D Coles
Mary J Holmay
Matthew Ahlskog
Melissa Terpstra
Usha Mishra
P2860
P304
P356
10.1097/WNF.0B013E31829AE713
P577
2013-07-01T00:00:00Z